Hauser SL, et al. Efficacy and safety of ofatumumab versus teriflunomide in relapsing multiple sclerosis: results of the phase 3 ASCLEPIOS I and II trials. Abstract 336. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Primaire auto-immuun hemolytische anemie geassocieerd met ischemisch CVA
feb 2024 | Benigne hematologie, Neuro-vasculair